Avascular Necrosis of the Scaphoid Preiser Disease



1 Orthopaedic Hand and Upper Extremity Service, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

2 The University of Texas at Austin, Austin, TX, USA


No consensus regarding optimal treatment or etiology of Preiser disease exists. We described the epidemiology,
classification and treatment characteristics of 18 patients with Preiser disease. Patients with changes related to previous
trauma, and without radiographs were excluded. Based on the radiographs at diagnosis, we classified 13 scaphoids as
Herbert Lanzetta stage II, four as stage III, and one as stage IV. In 12 patients nonspecific treatment was offered and
only two patients received surgical treatment. We found that chosen treatment is not associated with the severity of
Herbert Lanzetta stage and the outcome is not influenced by chosen treatment.
Level of evidence: I


Main Subjects